相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
Junpeng Ji et al.
ONCOLOGY REPORTS (2021)
Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype
Yousif A. Kariri et al.
PATHOBIOLOGY (2020)
CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
Guanghou Fu et al.
JOURNAL OF CANCER (2020)
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
Mansour Alsaleem et al.
MODERN PATHOLOGY (2019)
Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway
Aling Shen et al.
ONCOGENESIS (2019)
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer
Sasagu Kurozumi et al.
BRITISH JOURNAL OF CANCER (2019)
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma
Jing Xu et al.
EBIOMEDICINE (2019)
CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma
Hao Chen et al.
JOURNAL OF CANCER (2019)
Breast cancer genomics and immuno-oncological markers to guide immune therapies
D. Hammerl et al.
SEMINARS IN CANCER BIOLOGY (2018)
Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1
Zhengyuan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
Nam Nhut Phan et al.
Oncotarget (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
Yunhong Tian et al.
BMC CANCER (2018)
Role of triosephosphate isomerase and downstream functional genes on gastric cancer
Tingting Chen et al.
ONCOLOGY REPORTS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
Abir A. Muftah et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Multiple Levels of Regulation of Sororin by Cdk1 and Aurora B
Michael T. Borton et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma
Norihiko Tokuzen et al.
ONCOTARGET (2016)
Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer
Cansu Karakas et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer
Satu Luhtala et al.
TUMOR BIOLOGY (2016)
Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer
Mohammed A. Aleskandarany et al.
PATHOBIOLOGY (2015)
Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer
G. S. Falchook et al.
ANNALS OF ONCOLOGY (2013)
β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression
Babette Schade et al.
CANCER RESEARCH (2013)
Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies
Joseph Vijai et al.
PLOS GENETICS (2013)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The prognostic significance of lymphovascular invasion in invasive breast carcinoma
Emad A. Rakha et al.
CANCER (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression
Maryam Rezaei et al.
BREAST CANCER RESEARCH (2012)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl
Tomoko Nishiyama et al.
CELL (2010)
Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer
Bo Johanneson et al.
PROSTATE (2007)
Sororin is required for stable binding of cohesin to chromatin and for sister chromatid cohesion in interphase
Julia Schmitz et al.
CURRENT BIOLOGY (2007)
The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer
Phil Rolland et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
DM Abd El-Rehim et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance
EA Rakha et al.
HISTOPATHOLOGY (2005)
Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors
T Noguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
